South and Central America miRNA Sequencing and Assay Market
miRNA is a small noncoding RNA molecule of 20-30 nucleotides and play an important role in gene regulation. miRNA is partially complementary to messenger RNA (mRNA) and its main function is to downregulate gene expression. Since their discovery they have emerged as vital regulators of important cellular functions. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis.
Strategic insights for the South and Central America miRNA Sequencing and Assay provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 6.24 Million |
| Market Size by 2027 | US$ 13.84 Million |
| Global CAGR (2020 - 2027) | 10.6% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | South and Central America
|
| Market leaders and key company profiles |
The geographic scope of the South and Central America miRNA Sequencing and Assay refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The South and Central America miRNA sequencing and assay market is expected to reach US$ 13.84 million by 2027 from US$ 6.24 million in 2019; it is estimated to grow at a CAGR of 10.6% from 2020 to 2027. The market growth in this region is mainly attributed to the widening range of microRNA applications and rise in funding for genomics research. However, challenges related to the delivery, efficacy, and specificity of miRNA-based therapeutics hinder the market growth.
MicroRNAs (miRNAs) being involved in the process of differentiation, they act as markers in cell type identification. miRNAs are associated with pathological processes such as viral infections, autoimmune diseases, and carcinogenesis. Thus, extensive research is being conducted to identify new miRNAs. Furthermore, new discoveries regarding the role of miRNAs in disease development have made them a key target of novel therapeutic approaches. Several miRNA-targeted therapeutics against the diseases such as cancer and hepatitis have reached the clinical phase. For instance, Santaris Pharma has developed a therapeutic molecule named Miravirsen that targets miR-122 for the treatment of hepatitis C virus (HCV) infection; the molecule is in the Phase II clinical trial. Therefore, rise in funding of genomic research to identify new molecules to diagnose and treat diseases, and consequent expansion of the range of applications of miRNAs are driving the growth of the miRNA sequencing and assay market in South and Central America.
Countries in the are witnessing severe effects of the COVID-19 pandemic. Currently, these countries are rapidly boosting various clinical programs to manage this disease. The increasingly high focus on innovative diagnostic techniques that has resulted in growing adoption of sequencing and genomic assay methods. Eurofins genomics has donated 100,000 fast PCR tests to detect SARS-CoV-2 to hospitals in Brazil. In addition, the key players have also shifted their focus toward the development of advanced instruments and products, which could aid in COVID-19 diagnosis. Hence, the COVID-19 is supporting the South and Central America miRNA sequencing and assay market growth.
The South and Central America miRNA sequencing and assay market, by product, is segmented into library preparation and consumables. The consumables segment held a larger share of the market in 2019, whereas the library preparation segment is anticipated to register a higher CAGR in the market during the forecast period.
Based on technology, the South and Central America miRNA sequencing and assay market is segmented into sequencing by synthesis, nanopore, and ion semiconductor sequencing. The sequencing by synthesis segment held the largest share of the market in 2019; however, the nanopore segment is expected to register the highest CAGR in the market during 2020–2027.
Based on end user, the South and Central America miRNA sequencing and assay market is segmented into research institute, academia, and CROs. The research institute segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the period.
Some of the primary and secondary sources associated with this report on the South and Central America miRNA sequencing and assay market are the Pharmaceutical Research and Manufacturing Association (PhRMA), Organization for Economic Cooperation and Development (OECD), and US Food and Drug Administration (FDA).
The South and Central America miRNA Sequencing and Assay Market is valued at US$ 6.24 Million in 2019, it is projected to reach US$ 13.84 Million by 2027.
As per our report South and Central America miRNA Sequencing and Assay Market, the market size is valued at US$ 6.24 Million in 2019, projecting it to reach US$ 13.84 Million by 2027. This translates to a CAGR of approximately 10.6% during the forecast period.
The South and Central America miRNA Sequencing and Assay Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South and Central America miRNA Sequencing and Assay Market report:
The South and Central America miRNA Sequencing and Assay Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South and Central America miRNA Sequencing and Assay Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South and Central America miRNA Sequencing and Assay Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For South and Central America miRNA Sequencing and Assay Market
